Key Pharmacologic Principles and Drug-Drug Interactions in HIV Patient Care

  • Authors: Amanda H. Corbett, PharmD, BCPS, FCCP; Colin I. Sheffield, PharmD (More Info)
  • Section Editor: Eric S. Daar, MD
  • Editors in Chief: Daniel R. Kuritzkes, MD; Joseph J. Eron, Jr., MD
  • Last Reviewed: 6/3/19 (What's New)

Summary

  • Dose adjustments are required when coadministering pharmacologically boosted or unboosted atazanavir with histamine-2 receptor antagonists
  • Atazanavir should not be used unboosted alongside PPIs[FDA Atazanavir]

Action required